Related Experiment Video
Updated: Mar 17, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Association Between Alcohol Drinking Patterns and Multiple Metabolic Syndrome Components in Non-Obese and Obese
Ayako Kikuchi1,2, Hisashi Yoshimoto2,3, Takafumi Monma4
1Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba-shi, Japan.
Aim:
This cross-sectional study aimed to investigate the relationship between drinking patterns (combination of the frequency and amount of alcohol consumption) and the possession of multiple metabolic syndrome (MetS) components in non-obese and obese individuals.
Methods:
Data derived from medical examinations, specific health checkup questionnaires, and health insurance claims of 36 006 individuals aged 40-64 years from five health insurance associations affiliated with Japanese companies were analyzed. Modified Poisson regression analysis was conducted with multiple MetS components as the objective variable, drinking patterns as the explanatory variable, and sex, age, weight gain ≥ 10 kg since the age of 20 years, and lifestyle habits except for drinking patterns as adjustment variables.
Results:
Drinking patterns associated with a high risk of possessing multiple MetS components were "everyday drinking" ≥ 20 g/day and "sometimes drinking" ≥ 40 g/day in non-obese individuals and "everyday drinking" ≥ 60 g/day in obese individuals. Across these risky drinking patterns, the prevalence ratios for the possession of multiple MetS components were higher in non-obese individuals than in obese individuals. Conversely, drinking patterns associated with a lower risk of possessing multiple MetS components were "everyday drinking < 20 g/day" in non-obese individuals and "sometimes drinking < 20 g/day" and "everyday drinking < 20 g/day" in obese individuals.
Conclusion:
Non-obese individuals, even when drinking less frequently and in smaller amounts, showed a higher risk of possessing multiple MetS components than obese individuals, underscoring the importance of supporting reduced alcohol consumption among non-obese individuals.
Related Concept Videos
Obesity
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Stress Prevention and Stress Management Techniques IV
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

